Jim Cramer on Biogen Earnings, Alzheimer's Drug

2021-07-22 6

Jim Cramer breaks down his latest thoughts on Biogen's controversial Alzheimer's drug.

Free Traffic Exchange

Videos similaires

How Jim Cramer Is Approaching Eli Lilly Alzheimer's Drug Trial Results

Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'

Take Profits in Biogen, Jim Cramer Says

Biogen to ship Alzheimer's drug in two weeks

TheStreet Live Recap: Everything Jim Cramer Is Watching 4/23/21

TheStreet Live Recap: Everything Jim Cramer Is Watching 4/22/21

TheStreet Live Recap: Everything Jim Cramer Is Watching 3/31/21

TheStreet Live Recap: Everything Jim Cramer Is Watching 7/21/21

TheStreet Live Recap: Everything Jim Cramer Is Watching 7/13/21

TheStreet Live Recap: Everything Jim Cramer Is Watching 7/23/21

Web Analytics